Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (328)	11/9/2001 11:00:19 AM
From: scaram(o)uche	Respond to of 724

many responses, after looking at it for about a minute. need, immediately, to look at last quarters balance sheet. I'm shocked at the juicing of last quarter, but pleased with the commentary and operations figures. the question is, can we achieve and sustain "juiced". but, I was expecting 40% of $1 million more. Naive.

To: BulbaMan who wrote (328)	11/9/2001 11:29:29 AM
From: scaram(o)uche	Respond to of 724

shareholder equity up to 25,731 from 24,964. inventories to 16,766 from 16,905. accounts payable to 7,176 from 7,592.

To: BulbaMan who wrote (328)	11/9/2001 11:42:06 AM
From: scaram(o)uche	Respond to of 724

Well....... looks great to me. I was expecting $1M more in sales. Ugh. But, they've also come out of the closet as a bioterrorism play, and air samplers lead to automated plating which leads to incubators which lead to shakers which lead to freezers. Sort of like ankle bone, shin bone, knee bone......... Take that 526K and start multiplying by four. They've demonstrated that they can do it, and the company is being conservatively positioned for growth, IMO. Maybe I'm too optimistic, but I'm attracted to a solid, under valued company which is carrying 47% (disclaimer.......... whopping dilution coming, regardless of degree of success!!) of DGI's efforts.

To: BulbaMan who wrote (328)	11/9/2001 1:19:55 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 724

OK, looked at it now....... last qtr, income from operations plus DGI research plus severance costs was 1,292K. This qtr, it's 714. Margin dropped to 37%. Projecting sales forward four quarters, I had used them to estimate a value, based on a PE of 20. I had used $15 for a company value (no DGI), based on that analysis. That figure is obviously high. It looks more like $10 to me now. However, commentary in the release makes me enthusiastic that we can again look to that target within a year. That is, I feel that they'll do between 714 and 1,292 for a couple of quarters, while new efficiencies become even more of a focus. I worry about a write down for inventory. You asked for my comments. Are we going to get yours? It would be good to know if I'm missing something. As you know, DGI is an important part of my interest in NBSC.